Sober October for Neurological Disease
Donation protected
Last year I went alcohol free for the year and raised $1,600 for the Neurobiology, Stem Cells and Genetics (Bardy) Lab at SAHMRI, a non-profit organisation.
This lab focuses on neurological diseases such as Parkinson's, glioma (brain cancer) and major depression. The discoveries made in the Bardy lab also support progress in other neurological diseases such as dementia subtypes like Alzheimer's.
This year I aim to top last year's efforts and raise $2,000 for the lab. I will be taking part in 'Sober October'.
Dad was diagnosed with Parkinson's disease back in 2016, right around the time that I was recovering from major depressive disorder. I had grown up with a grandmother who had Alzheimer's and thought that neurological disease was just a part of life. I now know that we can do something to change this.
Parkinson's disease affects 1% of the population over 60. Current medicine only helps to mask the symptoms of the disease. Using stem cells reprogrammed from a skin biopsy of a patient with PD we can examine the properties of the brain cell culture, by combining functional and genetic analysis. This will allow us to compare neurons of the patient with a healthy subject in hopes of finding molecular targets to treat the disease.
http://www.bardylab.com/our-team.html
This lab focuses on neurological diseases such as Parkinson's, glioma (brain cancer) and major depression. The discoveries made in the Bardy lab also support progress in other neurological diseases such as dementia subtypes like Alzheimer's.
This year I aim to top last year's efforts and raise $2,000 for the lab. I will be taking part in 'Sober October'.
Dad was diagnosed with Parkinson's disease back in 2016, right around the time that I was recovering from major depressive disorder. I had grown up with a grandmother who had Alzheimer's and thought that neurological disease was just a part of life. I now know that we can do something to change this.
Parkinson's disease affects 1% of the population over 60. Current medicine only helps to mask the symptoms of the disease. Using stem cells reprogrammed from a skin biopsy of a patient with PD we can examine the properties of the brain cell culture, by combining functional and genetic analysis. This will allow us to compare neurons of the patient with a healthy subject in hopes of finding molecular targets to treat the disease.
http://www.bardylab.com/our-team.html
Organizer
Lucy Turner
Organizer
Burnside, SA